Antibodies are the future of cancer treatment
“Since President Nixon declared war on cancer in 1971, and despite some great victories and many losses, there continues to be a never-ending battle in this long-fought war that seems never-ending. The convergence of great intellect and resources of academia and industry, fueled by continued entrepreneurship and investment funding into the biotechnology sector, despite the many risks of failure and expense, is one that is obvious to yield the greatest rewards to both prosperity and health. Ultimately, targeted therapies will improve lifespans and quality of life for cancer patients.”
Eugene Chan is a health care executive.
He shares his story and discusses his KevinMD article, “Cancer of the future: diagnosis, treatment, and impact on the health care system and patients.”
Did you enjoy today’s episode?
Rate and review the show so more audiences can find The Podcast by KevinMD.
Subscribe on your favorite podcast app to get notified when a new episode comes out.
Click here to earn 1.0 AMA PRA Category 1 CME for this episode.
Also available in Category 1 CME bundles.
Powered by CMEfy – a seamless way for busy clinician learners to discover Internet Point-of-Care Learning opportunities that reward AMA PRA Category 1 Credit(s)™. Learn more at about.cmefy.com/cme-info
